Cash Flow from Operating Activities: A company's cash flows from operations.
Passage Bio, Inc. (PASG) had Cash Flow from Operating Activities of $-22.17M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-7.82M |
|
-- |
|
-- |
|
$8.27M |
|
$-8.27M |
|
$0.45M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-7.82M |
|
$-8.27M |
|
$-8.25M |
|
3.21M |
|
3.21M |
|
$-2.44 |
|
$-2.44 |
|
| Balance Sheet Financials | |
$25.18M |
|
-- |
|
-- |
|
$25.18M |
|
$20.72M |
|
-- |
|
-- |
|
$20.72M |
|
$4.46M |
|
$4.46M |
|
$4.46M |
|
3.22M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-22.17M |
$0.02M |
|
-- |
|
$46.30M |
|
$24.16M |
|
$-22.15M |
|
$1.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-175.52% |
|
-175.52% |
|
-31.07% |
|
-175.52% |
|
$1.38 |
|
$-6.90 |
|
$-6.91 |
|